Research on the Status Quo and Optimization of Centralized Procurement of Coronary Stents

Abstract

Objective To study the impact of the first national centralized procurement of coronary stents on patients’ psychology, the economy of medical institutions, and the survival and development of the coronary stents industry, and to provide suggestions on perfecting procedures to better carry out the centralized procurement of coronary stents. Methods Literature analysis was used to investigate the results of the procurement of coronary stent in a province and a hospital. Results and Conclusion The centralized procurement of coronary stents has alleviated the economic pressure of patients, but it has many problems. Therefore, this paper proposes some suggestions, such as promoting the orderly development of the coronary stent industry, improving the evaluation link of the centralized procurement of coronary stents, adopting the accurate reporting model to ensure the quality of coronary stents and improving the standardization of clinical services.

Keywords

volume procurement / coronary stent / medical resource

References

[1] Liu Qingfeng, Ran Jingfei. Analysis on the price formation of China’s high-value medical consumables and the effect of volume-based procurement policy[J]. Price: Theory & Practice, 2021 (2): 42-45.

[2] The Central People’s Government of the People’s Republic of China. Treatment of High-Value Medical Consumables[EB/OL]. (2019-07-31)[2022-06-16]. http://www.gov.cn/xinwen/2019-07/31/content_5417576.htm.

[3] McKavanagh P, Zawadowski G, Ahmed N, et al. The evolution of coronary stents[J]. Expert Review of Cardiovascular Therapy, 2018, 16 (3): 219-228.

[4] Shang Hui, Wen Taoyuan. Historical development and technological progress of domestic coronary stent[J]. China Medical Device Information, 2020, 26 (1): 10-13+155.

[5] Suryawan I, Luke K, Agustianto RF, et al. Coronary stent infection: A systematic review[J]. Coronary Artery Disease, 2022, 33 (4): 318-326.

[6] Gao H, Hu Y. Some practical problems and solutions caused by the centralized procurement system of medical consumables from the perspectives of economics [A]. The 2021 12th International Conference on E-business, Management and Economics[C]. New York: Association for Computing Machinery, 2021: 409-414.

[7] Xiao Guangzong. Discussion on the current situation and improvement measures of centralized procurement management of high-value medical consumables[J]. Enterprise Reform and Management, 2021 (23): 40-41.

[8] Li Huan, Zhang Zhiguo, Li Chenghong, et al. Comparative analysis on China’s volume-based procurement policy of medical consumables[J]. Chinese Journal of Health Policy, 2021, 14 (3): 48-56.

[9] Wei Guang, Wan Yong, Yang Shuo. Practice and consideration of the centralized procurement of high value medical consumables in Anhui[J]. China Health Insurance, 2020 (8): 47-50+54.

[10] Luo Nan. From January to August, the overall supply of coronary stent products was sufficient[N]. China Pharmaceutical News, 2021-09-09 (001).

[11] Dai Bin, Ye Xiaofang, Zhang Yumeng. Study on national procurement of coronary drug-eluting stent system in quantity[J]. China Tendering, 2021 (2): 113-117.

[12] Zhou Jingjing, Tan Zaixiang. Implementation and suggestions of centralized volume-based procurement of coronary stent by national organization[J]. Health Economics Research, 2021, 38 (11): 3-5.

[13] Wu Liping, Ding Jinxi, Li Wei. Evaluation on the implementation effect of centralized group procurement policy for high-value medical consumables - an empirical study on Jiangsu Province[J]. Price: Theory & Practice, 2021 (4): 54-57+124.

[14] Ou Fan, Li Dan, Chen Weixiong. The prediction of the influence of centralized procurement on the economic operation of medical institutions: A case study of coronary stent[J]. China Management Accounting Studies, 2021 (3): 68-72+88.

[15] Gao Feng, Liu Yan. An investigation into use of high-value medical consumables under national key governance in 56 hospitals of a city[J]. Modern Hospital, 2021, 21 (5):750-753.

[16] Zhang Hong, Yao Hui, Zeng Kaiqi, et al. Use of high-value medical consumables in governmental hospitals in Shenzhen under the new supervision mode[J]. Medical Equipment, 2021, 34 (18): 42-47.

[17] Lu Chong, Meng Xianghui, Zhang Lulu. Discussion on the centralized purchase and management of high-value medical consumables in medical institutions[J]. Hospital Management Forum, 2022, 39 (2): 14-16+10.

[18] Peng Weilian, Yi Qifeng, Shi Shuqing, et al. Clinical efficacy of drug-eluting coronary stents based on real-world data[J]. Journal of Central South University (Medical Science), 2021, 46 (7): 697-703.

[19] Jiang Changsong, Lu Chong, Ning Canjian. Prediction of domestic sales volume of the alternative products of the coronary stent under the condition of VBP[J]. China Health Insurance, 2021 (3): 65-68.

[20] Ning Yanyang. Bid opening for centralized procurement of coronary stents: What should we pay attention to besides price[J]. China Health, 2020 (12): 68-71.

[21] Leng Nannan, Qiu Yingpeng, Zhao Yuxi, et al. Analysis of the potential impact of the policy centralized procurement of coronary stents on the provision of medical services[J]. Health Economics Research, 2022, 39 (5): 1-3.

[22] Zeng Xuheng, Zheng Yi, Lv Jun, et al. SWOT analysis on volume-based procurement of high-value medical consumables: A case of Shanghai[J]. Chinese Journal of Health Policy, 2020, 13 (11): 37-42.

[23] Wei Guang, Hu Jian, Yuan Peng. Analysis and thinking on negotiation and negotiation of purchase of high-value medical consumables in quantity in Anhui Province[J]. Anhui Medical Journal, 2020, 41 (2): 214-217.

[24] Zhao Rong, Xia Haiming. Analysis on the use and medical insurance payment of high value medical consumables in a certain Nanjing public hospital[J]. Jiangsu Health System Management, 2021, 32 (9): 1203-1206.

[25] Tan Qingli, Zhou Zhiting. Research on medical insurance payment policy for centralized medical consumables volume-based purchasing[J]. Health Economics Research, 2021, 38 (11): 6-9.

[26] Tang Dongsheng. Procurement mode of high-value medical consumables under the new situation[J]. Medical Equipment, 2022, 35 (1): 89-91.